Infant screening company Natus floats on Nasdaq
This article was originally published in Clinica
Natus Medical saw its share price rise 36% to $15 after it floated on the Nasdaq national market earlier this month. The San Carlos, California company issued five million shares at $11. Its share price settled at $14 last week.